Literature DB >> 21671136

A new method of producing monoclinic paracetamol suitable for direct compression.

Andrey G Ogienko1, Elena V Boldyreva, Andrey Yu Manakov, Vladimir V Boldyrev, Alexander S Yunoshev, Anna A Ogienko, Svetlana A Myz, Alexei I Ancharov, Andrey F Achkasov, Tatiana N Drebushchak.   

Abstract

PURPOSE: To develop a technique of obtaining monoclinic polymorph of paracetamol suitable for direct compression without excipients.
METHODS: Preparation of spongy monoclinic paracetamol was based on quench-cooling of paracetamol solutions in water-acetone mixtures sprayed into a vessel with liquid nitrogen followed by removal of solvents by freeze-drying. X-ray powder diffraction was used to study annealing of quench-cooled solutions in "paracetamol-acetone-water" and "acetone-water" systems and to find optimum conditions for obtaining fine particles of pure monoclinic paracetamol. Samples were characterized by electron microscopy; compression properties were measured.
RESULTS: The preparation technique gave fine monoclinic paracetamol powder containing agglomerates (30-200 μm) composed of flat particles (linear sizes 1-10 μm, the thickness 60-150 nm). The spongy sample was suitable for direct compression without excipients, stable on storage, and mechanically robust. Mechanically stable tablets pressed from the spongy sample were better soluble in water than commercially available tablets of paracetamol with excipients.
CONCLUSIONS: The proposed method gave spongy monoclinic paracetamol samples with improved properties. For inexpensive paracetamol, the method may not yield economic advantage. However, the same method based on freeze-drying solutions in mixed aqueous-organic solvents can be used to prepare new improved forms of other molecular solids for pharmaceutical applications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21671136     DOI: 10.1007/s11095-011-0502-x

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  20 in total

1.  Polymorphism of paracetamol: relative stabilities of the monoclinic and orthorhombic phases inferred from topological pressure-temperature and temperature-volume phase diagrams.

Authors:  Philippe Espeau; René Céolin; Josep-Lluis Tamarit; Marc-Antoine Perrin; Jean-Pierre Gauchi; Franck Leveiller
Journal:  J Pharm Sci       Date:  2005-03       Impact factor: 3.534

Review 2.  Physical characterization of pharmaceutical formulations in frozen and freeze-dried solid states: techniques and applications in freeze-drying development.

Authors:  Jinsong Liu
Journal:  Pharm Dev Technol       Date:  2006-02       Impact factor: 3.133

3.  Mechanical activation of pharmaceutical systems.

Authors:  R Hüttenrauch; S Fricke; P Zielke
Journal:  Pharm Res       Date:  1985-11       Impact factor: 4.200

4.  Physicochemical characterization of the orthorhombic polymorph of paracetamol crystallized from solution.

Authors:  G Nichols; C S Frampton
Journal:  J Pharm Sci       Date:  1998-06       Impact factor: 3.534

5.  Polymers with pH-dependent solubility: possibility of use in the formulation of gastroresistant and controlled-release matrix tablets.

Authors:  G F Palmieri; S Michelini; P Di Martino; S Martelli
Journal:  Drug Dev Ind Pharm       Date:  2000-08       Impact factor: 3.225

6.  Dielectric solubility profiles in dioxane--water mixtures for several antipyretic drugs. Effect of substituents.

Authors:  A N Paruta; S A Irani
Journal:  J Pharm Sci       Date:  1965-09       Impact factor: 3.534

7.  Transforming powder mechanical properties by core/shell structure: compressible sand.

Authors:  Limin Shi; Changquan Calvin Sun
Journal:  J Pharm Sci       Date:  2010-11       Impact factor: 3.534

8.  Development of directly compressible powders via co-spray drying.

Authors:  Y Gonnissen; J P Remon; C Vervaet
Journal:  Eur J Pharm Biopharm       Date:  2007-01-18       Impact factor: 5.571

9.  In vitro drug release studies of polymeric freeze-dried wafers and solvent-cast films using paracetamol as a model soluble drug.

Authors:  Joshua S Boateng; Kerr H Matthews; Anthony D Auffret; Mike J Humphrey; Howard N Stevens; Gillian M Eccleston
Journal:  Int J Pharm       Date:  2009-05-27       Impact factor: 5.875

10.  The preparation and characterisation of drug-loaded alginate and chitosan sponges.

Authors:  Hui Ling Lai; Asad Abu'Khalil; Duncan Q M Craig
Journal:  Int J Pharm       Date:  2003-01-30       Impact factor: 5.875

View more
  2 in total

1.  Nanomechanical properties of selected single pharmaceutical crystals as a predictor of their bulk behaviour.

Authors:  Mateja Egart; Biljana Janković; Nina Lah; Ilija Ilić; Stanko Srčič
Journal:  Pharm Res       Date:  2014-08-05       Impact factor: 4.200

2.  Clathrate Hydrates of Organic Solvents as Auxiliary Intermediates in Pharmaceutical Research and Development: Improving Dissolution Behaviour of a New Anti-Tuberculosis Drug, Perchlozon.

Authors:  Andrey G Ogienko; Svetlana A Myz; Andrey A Nefedov; Anna A Ogienko; Tatyana P Adamova; Olga M Voronkova; Svetlana V Amosova; Boris A Trofimov; Vladimir V Boldyrev; Elena V Boldyreva
Journal:  Pharmaceutics       Date:  2022-02-24       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.